Members of The Conference Board get exclusive access to the full range of products and services that deliver Trusted Insights for What's Ahead ® including webcasts, publications, data and analysis, plus discounts to conferences and events.
20 January 2026 | Press Release
As the United States approaches the 250th anniversary of the Declaration of Independence, the Committee for Economic Development (CED), the public policy center of The Conference Board, has outlined this year’s critical policy challenges and how Washington can meet the moment.
In a letter sent to the President and Congressional leadership, CED emphasized the importance of bipartisan collaboration to advance policies that strengthen the nation’s long-term economic vitality, democratic institutions, and global competitiveness. Representing business leaders across more than 30 industries and over $2 trillion in revenues, CED will focus on three core priorities for the year ahead.
“As the nation reflects on its founding ideals, CED serves as a partner and resource for policymakers and business leaders to help realize these aspirations,” said David K. Young, President of CED. “This moment calls for pragmatic, bipartisan solutions that reinforce shared prosperity and the strength of American democracy.”
About The Conference Board
The Conference Board is the member-driven think tank that delivers Trusted Insights for What’s Ahead®®. Founded in 1916, we are a non-partisan, not-for-profit entity holding 501 (c) (3) tax-exempt status in the United States. TCB.org
The Committee for Economic Development (CED) is the public policy center of The Conference Board. The nonprofit, nonpartisan, business-led organization delivers well-researched analysis and reasoned solutions in the nation’s interest. CED Trustees are chief executive officers and key executives of leading US companies who bring their unique experience to address today’s pressing policy issues. Collectively, they represent 30+ industries and over 4 million employees. TCB.org/us/Committee-Economic-Development
Administration Strikes Deal on GLP-1 Drug Pricing and Coverage
November 18, 2025